Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease (Q22251240)

Dopamine dysregulation syndrome

Europe PubMed Central

title

Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease (English)

0 references

1 reference

0 references

1 reference

1 reference

2

Nir Giladi

Nir

Giladi

1 reference

PubMed

PubMed publication ID

7 February 2023

Doron Merims

1

Doron

Merims

1 reference

PubMed

PubMed publication ID

17988927

7 February 2023

language of work or name

English

0 references

publication date

May 2008

0 references

number of pages

8

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

0 references

volume

14

0 references

issue

4

0 references

page(s)

273-280

0 references

cites work

Pathological gambling caused by drugs used to treat Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Is there addiction to levodopa in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Compulsive drug use linked to sensitized ventral striatal dopamine transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Body weight gain rate in patients with Parkinson's disease and deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Compulsive eating and weight gain related to dopamine agonist use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Self-stimulatory behavior associated with deep brain stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Apomorphine-induced penile erections in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Hedonistic homeostatic dysregulation in Parkinson’s disease: a short screening questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

High rates of sexual behavior in the general population: correlates and predictors

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Study of compulsive buying in patients presenting obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Dopamine agonist therapy for Parkinson disease and pathological gambling

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Dopamine agonists and pathological gambling

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Hypersexuality in two patients with epilepsy treated with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Drug addiction, dysregulation of reward, and allostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Evidence for striatal dopamine release during a video game

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Dopamine D4 receptor polymorphism and idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Genetic susceptibility to substance dependence

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Levodopa dependence: a case report

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Sexual addiction, sexual compulsivity, sexual impulsivity, or what? Toward a theoretical model

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Sexual compulsivity among heterosexual college students.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

1 reference

7 January 2021

Hypersexuality with Antiparkinsonian Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Pathologic gambling in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Dopamine dysregulation syndrome in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Addiction and its brain science

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Levodopa addiction. A case study

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

The role of dopamine in reward and pleasure behaviour--review of data from preclinical research

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Drug abuse: hedonic homeostatic dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Obsessive-compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Parkinson's disease, personality, and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Serial cognitive profiles in levodopa-induced hypersexuality

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

The Sexual Compulsivity Scale: further development and use with HIV-positive persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Pathological gambling associated with dopamine agonist therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Levodopa addiction in idiopathic Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Is there a premorbid personality typical for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Nonmotor fluctuations in Parkinson's disease: frequent and disabling

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.09.007

7 January 2021

Dopamine D3 receptors regulate GABAA receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens.

1 reference